ロード中...
Successful management of a lung cancer patient harbouring both EGFR mutation and EML4-ALK fusion gene with disseminated intravascular coagulation
Lung cancer patients harbouring driver oncogene alterations are markedly responsive to molecular target agents, such as epidermal growth factor receptor (EGFR), tyrosine kinase inhibitor (TKI), and echinoderm microtubule-associated protein like 4 – anaplastic lymphoma kinase (EML4-ALK)-TKI. We encou...
保存先:
| 出版年: | Respir Med Case Rep |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Elsevier
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8024693/ https://ncbi.nlm.nih.gov/pubmed/33854939 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.rmcr.2021.101393 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|